Technology | September 23, 2014

ScanMed Introduces the World's First Wearable Prostate Coil

ScanMed Wearable Prostate Coil PROCURE

September 23, 2014 — ScanMed of Resonance Innovations introduced a world's first to the magnetic resonance imaging (MRI) market: The PROCURE Coil.

The latest product in ScanMed's Game-Changer coil line is the The PROCURE Coil (Prostate, Rectum, Ovaries, Cervix, Uterus,Reproductive). The PROCURE features a first-of-a-kind, lightweight SemiFlex design that facilitates effortless and accurate positioning. Similar to wearing a diaper, this dedicated MRI coil positions the multiple antenna elements as close as possible to the target anatomies regardless of patient size. The enclosure for the antenna set is made of flexible liquid impermeable, biocompatible materials. Accompanying this state-of-the-art product are disposable liners so that the coil can be easily changed between patients. 

This phased array coil can be configured to operate with an endorectal probe and also accommodates popular biopsy systems. ScanMed's revolutionary design offers improved SNR and uniformity that is needed for today's more aggressive protocols.

"There is an increase of the use of multi-parametric prostate MRI, as more and more urologists realize its significant value for early diagnosis," states Dr. Jelle Barentsz, Professor of Radiology at the Radboud Prostate MR-Reference Center in the Netherlands. "The prostate, however, is an organ that is located deep in the pelvis. Its distance to the surface is posteriorly, anteriorly and caudally significant. Therefore a special coil needs to be developed for optimal signal reception. The PROCURE has elements that also receive signal from the caudal part of the prostate. Its design therefore is unique. Initial results show an increased SNR compared to standard coils. Thus this coil potentially can visualize the prostate with improved resolution at same imaging time." Barentsz has become a leading specialist in Prostate MRI worldwide. He will serve as the course director at the ARRS Prostate MR Imaging Symposium in October, where ScanMed's executive team will be in attendance. ScanMed will also be showcasing their new product at multiple symposiums this fall.

For more information: www.scanmed.com

Related Content

This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
Hypofractionated Radiation Provides Same Prostate Cancer Outcomes as Conventional Radiation
News | Intensity Modulated Radiation Therapy (IMRT) | October 31, 2018
An analysis led by researchers at Philadelphia’s Fox Chase Cancer Center found treating localized prostate cancer with...
Prostate Brachytherapy Shows Low Incidence of Short-Term Complications
News | Brachytherapy Systems | October 31, 2018
A new analysis of nearly 600 men receiving brachytherapy for prostate cancer shows overall procedure-related...
Prostate Radiotherapy Outcomes Better for African-Americans Than Caucasian Patients according to a study presented at ASTRO 2018. #ASTRO #ASTRO18 #ASTRO2018
Feature | Prostate Cancer | October 30, 2018
October 30, 2018 — While popular beliefs and population data suggest that African-American men are at higher risk of
Fans of Opposing Soccer Teams Perceive Games Differently

Image courtesy of University of York

News | Neuro Imaging | October 25, 2018
Scientists have scanned the brains of die-hard soccer fans to find out why supporters of rival teams often have very...
IMRIS, Siemens Strengthen Collaboration in Hybrid OR Neurosurgical Market
News | Hybrid OR | October 24, 2018
IMRIS, Deerfield Imaging, in partnership with Siemens Healthineers, announced a strengthened collaboration to advance...
Carotid Artery MRI Improves Cardiovascular Disease Risk Assessment
News | Magnetic Resonance Imaging (MRI) | October 23, 2018
Magnetic resonance imaging (MRI) measurements of wall thickness in the carotid arteries improve cardiovascular disease...
Combined Therapy Including Pelvic Lymph Node Radiation Provides Significant Benefit for Prostate Cancer Patients - late breaking study presented at ASTRO 2018.
News | Prostate Cancer | October 22, 2018
The first report of a large, international clinical trial shows that, for men who show signs of...
The Elekta Unity with 1.5T MRI embedded as a targeting system appeared at the annual meeting of the American Society of Radiation Oncology (ASTRO) in San Antonio, Texas. The system is being sold in Europe and could soon enter the U.S. marketplace. (Photo courtesy of Elekta)

The Elekta Unity with 1.5T MRI embedded as a targeting system appeared at the annual meeting of the American Society of Radiation Oncology (ASTRO) in San Antonio, Texas. The system is being sold in Europe and could soon enter the U.S. marketplace. (Photo courtesy of Elekta)

Feature | ASTRO | October 20, 2018 | By Greg Freiherr
A linear accelerator combined with high-field MRI could soon be on the U.S. market. If U.S.